Ainsi, le présent profil peint le faciès épidémiologique du pays pour l’année 2015
avec un clin d’œil sur le niveau de réalisation des Objectifs du millénaire pour le
développement (OMD) et un focus particulier sur l’appropriation des Objectifs de
développement durable (ODD). Il e...st composé de six chapitres que sont (i)
Introduction au contexte du pays ; (ii) Etat et tendance des indicateurs de santé ; (iii)
Système de santé ; (iv) Progrès des objectifs de développement durable ; (v)
Programmes et services spécifiques ; (vi) Déterminants clés de la santé.
C’est un outil recommandé par l’OMS et est indispensable pour le pays en prélude à
la mise en place de l’Observatoire national de la santé. Son élaboration a connu un
processus participatif avec l’implication des différents acteurs intervenant dans le
domaine de la santé.
Profil sanitaire complet du Burkina Faso 2015 Page 8
Le document du profil pays a été organisé en 4 modules à savoir :
Module 1 : La situation socio-sanitaire du Burkina Faso et mise en œuvre des ODD ;
Module 2 : Le système de santé au Burkina Faso ;
Module 3 : Les programmes et services spécifiques de santé au Burkina Faso ;
Module 4 : Les déterminants clés de la santé.
more
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto...r vaccine against coronavirus disease 2019 (COVID-19). The vaccine expresses the SARS-CoV-2 spike protein gene, which instructs the host cells to produce the protein of the S-antigen unique to SARS-CoV-2, allowing the body to generate an immune response and to retain that information in memory immune cells. Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) irrespective of interval between the doses was 63.1%, based on a median follow-up of 80 days, but tended to be higher when this interval was longer. The data reviewed at this time support the conclusion that the known and potential benefits of ChAdOx1-S/nCoV-19 [recombinant] vaccine outweigh the known and potential risks.
more
MEDBOX Issue Brief No.17, 21 November 2021
Women's cancers have a significant impact on women's health worldwide. According to the World Health Organisation, nearly three million women are diagnosed with breast or cervical cancer every year. In this Issue Brief you will find more information.
7 April 2022. Aimed at national policymakers, public health and healthcare planners, staff working in reception centres, and healthcare staff caring for displaced persons, the information note concludes that universal testing of incoming refugees from Ukraine for tuberculosis (TB) infection is not r...ecommended. Specific groups, such as household contacts of bacteriologically confirmed pulmonary cases, or those who are immunocompromised should however be considered for TB infection testing.
Available in Czech, Hungarian, Polish, Romanian, Slovakian, Ukranian
more
180
Biomédica 2018;38:180-8
Describir el comportamiento epidemiológico de comorbilidades en
pacientes diagnosticados con tuberculosis de una institución prestadora de servicios
de salud (IPS) de Colombia, durante 2016 a 2019.
This document aims to provide guidance to countries in the identification of priority areas
for intervention as part of the Situational Analysis of their National Cholera Control or
Elimination Plans (NCPs).
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.